期刊文献+

铜陵市人民医院2006~2007年口服降糖药回顾性分析 被引量:1

Retrospective analysis on use of oral hypoglycemic agents
下载PDF
导出
摘要 目的了解近两年本院口服降糖药的临床使用情况和发展趋势,为临床合理用药提供参考。方法分别统计2006~2007年口服降糖药的年用药频度(DDDs)、日均费用(DDC),进行对照分析。结果本院2007年口服降糖药总DDDs值较2006年下降4.22%,2007年口服降糖药销售总金额较2006年下降11.63%。总体用药频度基本不变,而用药金额略有下降。结论随着药品价格的下调和新的降糖药的使用,疗效肯定、不良反应少的品种得到更多使用,临床作用更趋合理。 Aim To evaluate the clinical use and development of oral hypoglycemic agents in Tongling Pepole's Hospital to provide a ref- erence for rational use of drugs in clinical management. Method DDDs and DDC of hypoglyeemie drugs in the year of 2006 and 2007 were collected and analyzed. Result The total DDDs of OHA decreased 4.22 percent in 2007 in comparision to the in 2006, and the total amount of sales in 2007 decreased 11.63 percent compared with that in 2006. The total DDDs remain basically unchanged, while the sales of drug decreased. Conclusion With the reduction in drug price and the new OHA is used, more drugs with positively curative effects and low ADR are used, so the use of drug in clinic is more reasonable.
出处 《安徽医药》 CAS 2008年第10期969-970,共2页 Anhui Medical and Pharmaceutical Journal
关键词 降糖药 用药频度 合理用药 回顾性分析 oral hypoglycemic agents (OHA) DDDs rational use of Drugs (RUD) retrospective analysis
  • 相关文献

参考文献4

二级参考文献66

  • 1马凌燕,黄辉.噻唑烷二酮类药物的药理特点和临床评价[J].中国药房,2004,15(7):435-436. 被引量:17
  • 2曲彩红,杨莉,陶玲,朱惠敏,张永明,师晓嘉.2000年~2003年广东地区44家医院降糖药利用分析[J].中国药房,2005,16(1):42-44. 被引量:34
  • 3邹豪,邵元福,朱才娟,邓渝林,马玉杰,陈盛新.医院药品DDD数排序分析的原理及利用[J].中国药房,1996,7(5):215-217. 被引量:1426
  • 4Campbell RK.Glimepiride:a rode of a new sulfonylurea in the treatment of type 2 diabetes millitus[J].Ann Pharmacother,1998,32:1044.
  • 5van HEYNINGEN R. Formation of polyols by the lens of the rat with 'sugar' cataract[J]. Nature, 1959, 184:194-195.
  • 6SUZEN S, BUYUKBINGOL E. Recent studies of aldose reductase enzyme inhibition for diabetic complications[J]. Curt Med Chem, 2003, 10(15):1329-1352.
  • 7QUINN MT, GAUSS KA. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases[J]. J Leukoc Biol, 2004, 76(4):760-781.
  • 8BROWNLEE M, The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes, 2005, 54(6) : 1615-1625.
  • 9VINCENT AM, FELDMAN EL. New insights into the mechanisms of diabetic neuropathy[J]. Rev Endocr Metab Disord, 2004,5 (3) : 227 -236.
  • 10BOULTON AJM, MALIK RA, AREZZO JC, et al. Diabetic somatic neuropathies[J]. Diabetes Care, 2004, 27(6) : 1458-1486.

共引文献47

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部